For
Period Ended:
|
September
30, 2007
|
For
the Transition Period
Ended:
|
If
the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
|
|
Full
name of Registrant
|
Cytogen
Corporation
|
Former
name if applicable
|
Address
of principal executive office
(Street
and Number)
|
650
College Road East
|
City,
state and zip code
|
Princeton,
New Jersey 08540
|
ý
|
(a) The
reasons
described in reasonable detail in Part III of this form could not
be
eliminated without unreasonable effort or expense;
(b) The
subject
annual report, semi-annual report, transition report on Form 10-K,
Form
20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof,
will be
filed on or before the 15th calendar day following
the prescribed
due date; or the subject quarterly report or transition report
on Form
10-Q or subject distribution report on Form 10-D, or portion thereof,
will
be filed on or before the fifth calendar day following
the prescribed
due date; and
(c) The
accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
Kevin
J. Bratton
|
609
|
750-8205
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
Date:
November 9, 2007
|
CYTOGEN
CORPORATION
|
|
By:
|
/s/ KEVIN
J. BRATTON
|
|
Kevin
J. Bratton
|
||
Senior
Vice President, Finance, and
Chief
Financial
Officer
(Principal
Financial and Accounting Officer)
|